NXTM - Nxstage Medical, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue366,378336,123301,501
Cost of Revenue214,393204,652185,598
Gross Profit151,985131,471115,903
Operating Expenses
Research Development31,03226,23722,635
Selling General and Administrative125,238119,863115,455
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-4,285-14,629-22,187
Income from Continuing Operations
Total Other Income/Expenses Net-930561-10
Earnings Before Interest and Taxes-5,215-14,068-22,197
Interest Expense1,0001,115863
Income Before Tax-6,215-15,183-23,060
Income Tax Expense1,1021,0771,253
Minority Interest6251,6941,088
Net Income From Continuing Ops-4,771-15,342-23,946
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-4,771-15,342-23,946
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-4,771-15,342-23,946